In this review
Choose a clinical question before a larger catalogue
The current carousel lists NAD+, sermorelin and glutathione injections, each as low as $89, alongside injectable and oral weight-care options. It does not establish a complete supplied period, formulation or quantity for those injection prices. Treat them as separate offers requiring a complete prescription description. [1]
Identify the actual dispensing pharmacy and clinical provider rather than infer them from a partner list or broad medical-team language. The terms distinguish the platform from independent care, and the consent acknowledges the limits of remote assessment. A catalogue alone does not establish that combining services is appropriate. [2] [3]
Keep a measured marker separate from a meaningful health outcome with the biological-age testing evidence.
Define the follow-up that earns its place in the budget
The home page advertises 24/7 medical access, but its pricing, plan-inclusions and after-sign-up FAQ answers all currently repeat payment-method information. They do not define appointments, a laboratory panel or the next bill. Ask what can actually be booked and which monitoring costs are included for the selected service. [1]
The terms allow separate charges for care outside the offered service and recurring fees for subscriptions. Confirm the actual amount due, supply period, follow-up interval and renewal date. Several low entry figures should not be added together and treated as the cost of a complete preventive-care programme. [2]
Separate the actual tests, visits and prescriptions in the health-service cost planner.
A renewal cancellation does not settle the current order
Subscription terms allow automatic continuation unless notice arrives before a charge. They also permit charging a treatment request before onboarding and provider approval are finished. Establish the actual order stages and the financial result of medical nonapproval before submitting the request. [2]
Processed orders may not be refundable, and discounted purchases may have further refund limitations. The terms reference a separate billing/returns policy; ask for the applicable complete procedure. The forty-eight-hour appointment-cancellation provision is not a general prescription return window. A clinical recommendation should come with an understandable purchase agreement. [2]
Compare another broad catalogue and purchase agreement in our Sunlight service-and-commitment review.
Compare another consultation and refund arrangement in our EverFit Medical care-and-order review.
Compare another recurring purchase and cancellation arrangement in our Vytora Health purchase-terms review.
Do not let a general approval line answer a product question
The homepage broadly refers to FDA-approved medication without specifying the actual preparation for every listed service. The consent separately addresses patients receiving compounded prescriptions, which are not FDA-approved. Identify the exact product and purpose rather than infer regulatory status from the catalogue heading. [1] [3] [4]
I would compare Velvet after the preparation, necessary monitoring and continuing cost are established. State-specific availability also remains qualified in the terms. Convenient online access or a larger treatment menu does not establish improved healthy lifespan, and weight-loss testimonials should not be extended into evidence for NAD+ or sermorelin. [1] [2]
Compare another preparation and follow-up description in the KIN Meds service-scope review.
Understanding the cost
NAD+, sermorelin and glutathione are each listed as low as $89; weight-care figures are separately $99 semaglutide, $179 tirzepatide and $149 oral GLP-1. These are entry figures without complete selected supply or renewal totals, not a combined-service package.
Build your cost estimateSources
- Velvet Rx: current injectable/oral catalogue, starting prices and expanded care/pricing FAQs
- Velvet Rx: full payment, renewal, processed-order refund and appointment terms
- Velvet Rx: clinical assignment, telehealth limits and conditional compounding consent
- FDA: compounded drugs and premarket approval limits
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.